Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.

Hoffman, William H; Cudrici, Cornelia D; Boodhoo, Dallas; Tatomir, Alexandru; Rus, Violeta; Rus, Horea

Hoffman, William H; Cudrici, Cornelia D; Boodhoo, Dallas; Tatomir, Alexandru; Rus, Violeta; Rus, Horea.

Affiliation

Hoffman WH; Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Cudrici CD; Translational Vascular Medicine Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA.
Boodhoo D; Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD, USA.
Tatomir A; Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD, USA.
Rus V; Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland, School of Medicine, Baltimore, MD, USA.
Rus H; Department of Neurology, University of Maryland, School of Medicine, Baltimore, MD, USA. Electronic address: hrus@umaryland.edu.

Exp Mol Pathol ; 108: 97-104, 2019 06.

Article de En | MEDLINE | ID: mdl-30986397

Sujet(s)
Mots clés

C5b-9; Diabetic ketoacidosis; Matrix metalloproteinase 9; RGC-32; Tissue inhibitor of metalloproteinases 1

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Acidocétose diabétique / Matrix metalloproteinase 9 Limites: Adolescent / Female / Humans Langue: En Journal: Exp Mol Pathol Année: 2019 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google